China Pharma Holdings EBITDA 2010-2023 | CPHI
China Pharma Holdings ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
China Pharma Holdings Annual EBITDA
(Millions of US $) |
| 2023 |
$0 |
| 2022 |
$-1 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$-17 |
| 2018 |
$-7 |
| 2017 |
$-15 |
| 2016 |
$-5 |
| 2015 |
$-11 |
| 2014 |
$-37 |
| 2013 |
$-17 |
| 2012 |
$7 |
| 2011 |
$23 |
| 2010 |
$26 |
| 2009 |
$24 |
China Pharma Holdings Quarterly EBITDA
(Millions of US $) |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$-0 |
| 2023-06-30 |
$0 |
| 2023-03-31 |
$0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-0 |
| 2022-06-30 |
$-0 |
| 2022-03-31 |
$-0 |
| 2021-12-31 |
$0 |
| 2021-09-30 |
$0 |
| 2021-06-30 |
$-0 |
| 2021-03-31 |
$0 |
| 2020-12-31 |
$-0 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
$1 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$-18 |
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
$-7 |
| 2018-09-30 |
$-1 |
| 2018-06-30 |
$-0 |
| 2018-03-31 |
$1 |
| 2017-12-31 |
$-13 |
| 2017-09-30 |
$-1 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$-3 |
| 2016-09-30 |
$-1 |
| 2016-06-30 |
$-1 |
| 2016-03-31 |
$-0 |
| 2015-12-31 |
$-14 |
| 2015-09-30 |
$4 |
| 2015-06-30 |
$2 |
| 2015-03-31 |
$-3 |
| 2014-12-31 |
$-21 |
| 2014-09-30 |
$-6 |
| 2014-06-30 |
$-8 |
| 2014-03-31 |
$-2 |
| 2013-12-31 |
$-8 |
| 2013-09-30 |
$-2 |
| 2013-06-30 |
$-4 |
| 2013-03-31 |
$-3 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$2 |
| 2012-06-30 |
$3 |
| 2012-03-31 |
$4 |
| 2011-12-31 |
$5 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$6 |
| 2011-03-31 |
$6 |
| 2010-12-31 |
$8 |
| 2010-09-30 |
$7 |
| 2010-06-30 |
$6 |
| 2010-03-31 |
$5 |
| 2009-12-31 |
$6 |
| 2009-09-30 |
$8 |
| 2009-06-30 |
$5 |
| 2009-03-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
